Free or Total 25OHD as Marker for Vitamin D Status?

Journal of Bone and Mineral Research

Volumn 31, Issue 6, 2016, Pages 1124-1127

  Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; HYDROCORTISONE; MEGALIN; MONOCLONAL ANTIBODY; TESTOSTERONE; THYROID HORMONE; VITAMIN D; VITAMIN D BINDING PROTEIN; BIOLOGICAL MARKER; VITAMIN;

AFRICAN AMERICAN; BIOAVAILABILITY; BLACK PERSON; BONE DENSITY; CAUCASIAN; CHRONIC KIDNEY FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUILIBRIUM DIALYSIS; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENETIC DIFFERENCE; GENETIC VARIATION; GENOTYPE; HUMAN; IMMUNOASSAY; KIDNEY TUBULE CELL; NOTE; PARATHYROID HORMONE BLOOD LEVEL; RACE DIFFERENCE; SALIVA LEVEL; STANDARDIZATION; TANDEM MASS SPECTROMETRY; THYROID DISEASE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

BIOMARKERS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN; VITAMINS;

EID: 84971515757     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2871     Document Type: Note

References (35)

1. Denburg MR, Hoofnagle AN, Sayed S, et al., Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Miner Res. 2016; 31: 1128-36.
2. Powe CE, Evans MK, Wenger J, et al., Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369 (21): 1991-2000.
3. Bouillon R, Vanassche FA, Vanbaelen H, Heyns W, Demoor P., Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3-significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest. 1981; 67 (3): 589-96.
4. Bikle DD, Gee E, Halloran B, Haddad JG., Free 1,25-dihydroxyvitamin-D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984; 74 (6): 1966-71.
5. Bouillon B., The vitamin D binding protein. In: Feldman D, Pike JW, Adams J, editors. Vitamin D. London: Elsevier; 2011. p. 57-72.
6. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG., Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63 (4): 954-9.
7. Aloia J, Dhaliwal R, Mikhail M, et al., Free 25(OH)D and calcium absorption, PTH, and markers of bone turnover. J Clin Endocrinol Metab. 2015; 100 (11): 4140-5.
8. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M,. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014; 144 Pt A: 132-7.
9. Faix JD., Principles and pitfalls of free hormone measurements. Best Pract Res Clin Endocrinol Metab. 2013; 27 (5): 631-45.
10. Antonio L, Wu FC, O'Neill TW, et al., Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone. J Clin Endocrinol Metab. Epub 2016 Feb 24: jc20154106.
11. Marzolo MP, Farfan P., New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res. 2011; 44 (1): 89-105.
12. Schwartz JB, Lai J, Lizaola B, et al., A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab. 2014; 99 (5): 1631-7.
13. Heureux N, Anciaux M, Poncelet M, et al., Development of an ELISA for the measurement of free 25OH vitamin D. Endocr Abstracts. 2015; 37:abstract EP223.
14. Holick MF., Bioavailability of vitamin D and its metabolites in black and white adults. N Engl J Med. 2013; 369 (21): 2047-8.
15. Bouillon R, Jones K, Schoenmakers I., Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med. 2014; 370 (9): 879.
16. Henderson CM, Lutsey PL, Misialek JR, et al., Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem. 2016; 62 (1): 179-87.
17. Nielson CM, Jones KS, Chun RF, et al., Role of assay type in determining free 25-hydroxyvitamin D levels in diverse populations. N Engl J Med. 2016; 374 (17): 1695-6.
18. Nielson CM, Jones KS, Chun RF, et al., Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations. J Clin Endocrinol Metab. 2016; 101 (5): 2226-34.
19. Jemielita TO, Leonard MB, Baker J, et al., Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int. 2016; 27 (2): 617-26.
20. Sollid ST, Hutchinson MY, Berg V, et al., Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol. 2016; 174 (4): 445-52.
21. Bouillon R., The power of mass spectroscopy as arbiter for immunoassays. Clin Chem. 2016; 62 (1): 6-8.
22. Arnaud J, Constans J., Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993; 92 (2): 183-8.
23. Kawakami M, Imawari M, Goodman DS., Quantitative studies of the interaction of cholecalciferol (vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. Biochem J. 1979; 179 (2): 413-23.
24. Boutin B, Galbraith RM, Arnaud P., Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D. J Steroid Biochem. 1989; 32 (1A): 59-63.
25. Bouillon R, van Baelen H, de Moor P., Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem. 1980; 13 (9): 1029-34.
26. Verboven C, Ragijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C., A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol. 2002; 9 (2): 131-6.
27. Alzaman N, Dawson-Hughes B, Nelson J, D'Alessio DA, Pittas AG., Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. Poster presented at: ENDO 2016: the Endocrine Society Annual Meeting; April 1-4, 2016; Boston, MA. SAT 344.
28. Bhan I, Powe CE, Berg AH, et al., Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012; 82 (1): 84-9.
29. Dastani Z, Berger C, Langsetmo L, et al., In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations. J Bone Miner Res. 2014; 29 (2): 494-9.
30. Johnsen MS, Grimnes G, Figenschau Y, Torjesen PA, Almas B, Jorde R., Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand J Clin Lab Invest. 2014; 74 (3): 177-83.
31. Powe CE, Ricciardi C, Berg AH, et al., Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011; 26 (7): 1609-16.
32. Srikanth P, Chun RF, Hewison M, et al., Associations of total and free 25OHD and 1,25(OH)D with serum markers of inflammation in older men. Osteoporos Int. Epub 2016 Feb 23.
33. Schwartz JB, Kane L, Bikle D., Response of vitamin D concentration to vitamin D3 administration in older adults without sun exposure: a randomized double-blind trial. J Am Geriatr Soc. 2016; 64 (1): 65-72.
34. Collins FS, Tabak LA,. Policy: NIH plans to enhance reproducibility. Nature. 2014; 505 (7485): 612-3.
35. Manolagas SC, Kronenberg HM,. Reproducibility of results in preclinical studies: a perspective from the bone field. J Bone Miner Res. 2014; 29 (10): 2131-40.